New Drug Combination Has Potential to Treat Non-small Cell Lung Cancer

Moffitt Cancer Center study finds combination treatment of pembrolizumab and vorinostat is well tolerated, showing preliminary efficacy of therapy for lung cancer patients.

from Medindia Health News https://ift.tt/2NAyzgz